For the past 75 years, Boyden has been instrumental in the evolution of executive search. As a leader in our industry, we’ve set the standard for others to follow, and we continue to evolve our services, blaze new trails and tear down old barriers.
Our commitment to fighting racism, gender discrimination and social injustice is evident in the causes we are passionately aligned with — causes that harness the power of unity into a single voice to advance diversity and inclusion in business and society.
"The bottom line: management diversity is good for business. Challenging and taking action against the status quo is the only way forward - to disrupt ourselves; to acknowledge our role as advocates and active contributors towards progress.”
– Chad Hesters, President & CEO, Boyden
We challenge and address the narrow paths to leadership over the course of our work and as we continue to build global partnerships, affiliations and Boyden programs focused on action-oriented solutions.
We invite you to learn more about our trusted advisor approach to DEI here and to learn about our global partnerships supporting diversity, equity and inclusion by selecting any of the initiatives below:
Conversations designed with purpose to inspire and empower women along their board director journey. This edition features Judith Athaide, corporate director for HSBC Bank Canada, Kiwetinohk Energy Corp., New Brunswick Power, Sustainable Development Tech. Canada, and more; in discussion with Boyden's Lisa Kershaw.
Boyden’s Global Financial Services Practice welcomed special guests Ken Hugessen and John Skinner from Hugessen Consulting to discuss ‘Challenges for Bank Boards in North America Regarding CEO Compensation in a Changing Landscape’. Here we share insights and key trends.
Conversations designed with purpose to inspire and empower women along their board director journey. This edition features Dr. Nadine Beauger, Présidente - Directrice Générale / President & CEO of IRICoR and Board Director for CHU Ste-Justine Foundation, ExCellThera, and Immune BioSolutions, in discussion with Boyden's Chantal Hevey.